Technology
Health
Medical

electroCore

$1.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell electroCore and other stocks, options, ETFs, and crypto commission-free!

About ECOR

electroCore, Inc. Common Stock, also called electroCore, is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. Read More The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.

Employees
91
Headquarters
Basking Ridge, New Jersey
Founded
2005
Market Cap
37.04M
Price-Earnings Ratio
Dividend Yield
Average Volume
127.46K
High Today
$1.28
Low Today
$1.25
Open Price
$1.28
Volume
133.10K
52 Week High
$17.99
52 Week Low
$1.25

Collections

Technology
Health
Medical
Therapy
2018 IPO
US
North America

ECOR Earnings

-$0.54
-$0.51
-$0.48
-$0.45
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.45 per share
Actual
Expected Aug 12, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.